共查询到18条相似文献,搜索用时 187 毫秒
1.
2.
基于液相色谱-质谱技术的代谢组学分析方法新进展 总被引:1,自引:0,他引:1
液相色谱-质谱联用技术是代谢组学研究领域的主要技术平台之一,近年来基于液相色谱-质谱联用技术的代谢组学分析方法获得了巨大发展。本文结合本研究组在代谢组学方面的研究成果,综述了近年来液相色谱-质谱联用技术在代谢组学分析方法方面的新进展,并对其发展前景进行了展望。综述引用文献41篇。 相似文献
3.
分别从中药成分分析、活性筛选和代谢组学三方面对质谱技术在中药研究中的应用进展进行了全面综述.在中药成分分析方面,重点介绍了寡糖异构体的分析方法,以及质谱指纹图谱技术在中药成分分析及质量控制中的应用;在活性筛选方面,分别介绍了超滤-质谱、细胞膜色谱-质谱、微透析-质谱、亲和色谱-质谱、强度衰减质谱、修饰琼脂糖珠-质谱和直接分析质谱等技术及其应用;在代谢组学研究方面,对中药治疗肝损伤、肾虚、心肌梗死和糖尿病等疾病方面的研究进展进行了阐述.上述内容充分反映了质谱技术在中药创新性研究中的重要性. 相似文献
4.
5.
6.
通过高效液相色谱-四极杆飞行时间质谱(HPLC-Q-TOF/MS)分别对肺癌细胞与正常细胞的极性与非极性代谢物进行指纹图谱分析,进一步应用偏最小二乘判别分析(PLS-DA)对代谢组学数据进行多维统计分析。研究结果显示,与正常细胞相比,肿瘤细胞存在异常的蛋白质、脂肪酸、磷脂代谢,并发现31种对分类有显著贡献的代谢小分子物质。通过本研究,建立了基于液相色谱-质谱联用技术的肺癌细胞代谢组学分析方法,发现了肺癌潜在疾病标记物,可为肺癌分子标记物的发现及其早期诊断提供新思路和新方法。 相似文献
7.
8.
1 全二维气相色谱与质谱联用系统的最新进展 2 二维液相色谱优化方法的最新进展 3 集成在微流控芯片上的二维液相色谱-毛细管电泳-电喷雾离子化系统 4 基于二维色谱-质谱的磷脂全分析方法及其在帕金森症代谢组学研究中应用 相似文献
9.
高血压病肝阳上亢证血清代谢指纹图谱研究 总被引:1,自引:0,他引:1
根据临床高血压病肝阳上亢证的诊断标准,选择典型病例,以高效液相色谱-质谱联用技术分析高血压病肝阳上亢证患者和健康志愿者的血清成分,采用"中药色谱指纹图谱相似度评价系统"对齐、匹配色谱峰,采用PCA方法进行模式识别,以MS检测标记物分子量。两组高效液相色谱数据可以在得分图实现分类,与健康志愿者作比较,患者机体相关代谢发生显著变化。高效液相色谱质谱联用结合PCA模式识别的代谢组学方法可用于研究复杂条件下机体病理的生理变化,为高血压病肝阳上亢证病证诊断提供科学依据。 相似文献
10.
11.
Strategy for metabonomics research based on high-performance liquid chromatography and liquid chromatography coupled with tandem mass spectrometry 总被引:12,自引:0,他引:12
Yang J Xu G Zheng Y Kong H Wang C Zhao X Pang T 《Journal of chromatography. A》2005,1084(1-2):214-221
Metabonomics, the study of metabolites and their roles in various disease states, is a novel methodology arising from the post-genomics era. This methodology has been applied in many fields. Current metabonomic practice has relied on mass spectrometry (MS), gas chromatography-mass spectrometry (GC-MS), and nuclear magnetic resonance (NMR) to analyze metabolites. In this study, a strategy was developed for applying high-performance liquid chromatography (HPLC) and LC-MS-MS to metabonomics research. One of the key problems to be solved in this strategy is to match the peaks between the chromatograms. A peak alignment algorithm has been developed to match the chromatograms before the pattern recognition. As an application example, the strategy described above was applied to metabonomics research on liver diseases, and the false-positive result of live cancer diagnosis from the hepatocirrhosis and hepatitis diseases was effectively reduced to 7.40%. Based on the pattern recognition, several potential biomarkers were found and further identified by the following LC-MS-MS experiments. The structures of eight potential biomarkers were given for distinguishing the liver cancer from the hepatocirrhosis and hepatitis diseases. 相似文献
12.
13.
14.
15.
16.
应用代谢组学研究方法,对与膀胱癌(Bladder cancer,BC)发病相关的生物标志物进行筛选,采用液相色谱-电喷雾质谱(LC-ESI/MS)联用技术对20名膀胱癌患者与24名正常人的血清和尿液进行研究.多变量统计分析结果表明,膀胱癌患者和正常人聚类明显,血清和尿液中分别发现13个潜在标志物.其中,(2E,6E,8E)-二十二碳三烯-1-醇、7-((1S,2S)-2-(庚胺)环己基)庚酸和(11E,14E,17E)-三烯-二十碳-1-醇首次在血清中发现,有潜力成为膀胱癌诊断标志物.液相色谱-质谱联用结合多变量分析的代谢组学研究技术在膀胱癌诊断中展现出巨大潜力. 相似文献
17.
18.
Robosky LC Robertson DG Baker JD Rane S Reily MD 《Combinatorial chemistry & high throughput screening》2002,5(8):651-662
Metabonomics is an emerging technology that enables rapid in vivo screening for toxicity, disease state, or drug efficacy. The technology combines the power of high-resolution nuclear magnetic resonance (NMR) techniques with statistical data analysis methods to rapidly evaluate the metabolic "status" of an animal. Complimentary to other profiling technologies like proteomics and genomics, metabonomics provides a fingerprint of the small-molecules contained in a given biofluid through the time course of a study. This article reviews the steps in implementing a metabonomics-based screening program from study design through data analysis. While metabonomics is still a relatively new technology in comparison to the other "omics", published results from metabonomics studies demonstrate its potential impact in the drug discovery process by enabling the incorporation of safety endpoints much earlier in the drug discovery process, reducing the likelihood (and cost) of later stage attrition. 相似文献